Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
corticosteroid-binding globulin deficiency | SERPINA6* | Serpina6* | 2 models | Alliance of Genome Resources | |||
primary hyperaldosteronism | CLCN2* | Clcn2* | 1 model | Alliance of Genome Resources | |||
X-linked adrenal hypoplasia congenita | NR0B1* | Nr0b1* | 1 model | Alliance of Genome Resources | |||
adrenal gland disease | MRAP | Mrap* | 1 model | Alliance of Genome Resources | |||
primary hyperaldosteronism | CRH | Crh* | 1 model | Alliance of Genome Resources | |||
primary hyperaldosteronism | DRD2 | Drd2* | 1 model | Alliance of Genome Resources | |||
primary hyperaldosteronism | NR3C1 | Nr3c1* | 1 model | Alliance of Genome Resources | |||
primary pigmented nodular adrenocortical disease | PRKAR1A | Prkar1a* | 1 model | Alliance of Genome Resources | |||
ACTH-independent macronodular adrenal hyperplasia 1 | GNAS* | Gnas | Alliance of Genome Resources | ||||
ACTH-independent macronodular adrenal hyperplasia 2 | ARMC5* | Armc5 | Alliance of Genome Resources | ||||
Addison's disease | CLEC16A* | Clec16a | Alliance of Genome Resources | ||||
Addison's disease | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
Addison's disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
Addison's disease | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
Addison's disease | CIITA* | Ciita | Alliance of Genome Resources | ||||
adrenal carcinoma | PTN* | Ptn | Alliance of Genome Resources | ||||
adrenal cortical adenoma | PRKACA* | Prkaca | Alliance of Genome Resources | ||||
congenital adrenal insufficiency | CYP11A1* | Cyp11a1 | Alliance of Genome Resources | ||||
corticosterone methyloxidase deficiency 1 | CYP11B2*, CYP11B1 | Cyp11b1, Cyp11b2 | Alliance of Genome Resources | ||||
familial glucocorticoid deficiency | NNT* | Nnt | Alliance of Genome Resources | ||||
familial glucocorticoid deficiency | MRAP* | Mrap | Alliance of Genome Resources | ||||
familial glucocorticoid deficiency | TXNRD2* | Txnrd2 | Alliance of Genome Resources | ||||
glucocorticoid deficiency 1 | MC2R* | Mc2r | Alliance of Genome Resources | ||||
glucocorticoid-remediable aldosteronism | CYP11B1*, CYP11B2 | Cyp11b1, Cyp11b2 | Alliance of Genome Resources | ||||
primary hyperaldosteronism | CYP11B1*, CYP11B2* | Cyp11b1, Cyp11b2 | Alliance of Genome Resources | ||||
primary hyperaldosteronism | CACNA1H* | Cacna1h | Alliance of Genome Resources | ||||
primary hyperaldosteronism | KCNJ5* | Kcnj5 | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 1 | PRKAR1A* | Prkar1a | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 2 | PDE11A* | Pde11a | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 3 | PDE8B* | Pde8b | Alliance of Genome Resources | ||||
primary pigmented nodular adrenocortical disease 4 | PRKACA* | Prkaca | Alliance of Genome Resources |
Transgenes and other genome features developed in mice to model this disease.
|
|||
Disease Term | Transgenes and Other Genome Features | Mouse Models | |
primary hyperaldosteronism | Tg(Crh)227.1Pbl | 1 model | |
primary pigmented nodular adrenocortical disease | Tg(tetO-Prkar1a*x2as)1Stra | 1 model |